BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 35701134)

  • 21. Efficacy and Economic Evaluation of Nonbiological Artificial Liver Therapy in Acute-on-chronic Hepatitis B Liver Failure.
    Wu C; Peng W; Cheng D; Gu H; Liu F; Peng S; Fu L
    J Clin Transl Hepatol; 2023 Apr; 11(2):433-440. PubMed ID: 36643036
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Administration of recombinant human thrombopoietin is associated with alleviated thrombocytopenia in adult intensive care unit patients with pneumonia: A single-center retrospective study.
    Chen B; Xuan J; Wu F; Shi N; Dai J; Cai S; An S; Huang Q; Huang X; Chen Z; Zeng Z
    Front Pharmacol; 2022; 13():1007719. PubMed ID: 36299903
    [No Abstract]   [Full Text] [Related]  

  • 23. Recombinant human thrombopoietin in critically ill patients with sepsis-associated thrombocytopenia: A clinical study.
    Liu Y; Jin G; Sun J; Wang X; Guo L
    Int J Infect Dis; 2020 Sep; 98():144-149. PubMed ID: 32561426
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recombinant human thrombopoietin treatment in patients with chronic liver disease-related thrombocytopenia undergoing invasive procedures: A retrospective study.
    Ding JN; Feng TT; Sun W; Cai XY; Zhang Y; Zhao WF
    World J Gastrointest Surg; 2022 Nov; 14(11):1260-1271. PubMed ID: 36504518
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recombinant human thrombopoietin is an effective treatment for thrombocytopenia in hemophagocytic lymphohistiocytosis.
    Wang Y; Wang Z; Wu L; Zhang J; Wang J; Yan L
    Ann Hematol; 2013 Dec; 92(12):1695-9. PubMed ID: 23778995
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety and Efficacy of Regional Citrate Anticoagulation during Plasma Adsorption Plus Plasma Exchange Therapy for Patients with Acute-on-Chronic Liver Failure: A Pilot Study.
    Ma Y; Chen F; Xu Y; Wang M; Zhou T; Lu J; Feng P; Wang Y; Bai L; Tang H
    Blood Purif; 2019; 48(3):223-232. PubMed ID: 31216551
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect of recombinant human thrombopoietin on platelets in rats with D-galactosamine salt-induced acute liver failure].
    Tang F; Liang J; Jing L; Liu G; Wang F
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2024 Feb; 36(2):189-194. PubMed ID: 38442937
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic plasma exchange versus double plasma molecular absorption system in hepatitis B virus-infected acute-on-chronic liver failure treated by entercavir: A prospective study.
    Wan YM; Li YH; Xu ZY; Yang J; Yang LH; Xu Y; Yang JH
    J Clin Apher; 2017 Dec; 32(6):453-461. PubMed ID: 28304106
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [A multi-center clinical trial of recombinant human thrombopoietin in the treatment of chemotherapy-induced thrombocytopenia in patients with solid tumor].
    Bai CM; Xu GX; Zhao YQ; Han SM; Shan YD
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Aug; 26(4):437-41. PubMed ID: 15379272
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical tolerance test of recombinant human thrombopoietin].
    Zhao Y; Jiang J; Jiao L
    Zhonghua Yi Xue Za Zhi; 2001 Dec; 81(24):1508-11. PubMed ID: 16200777
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety and efficacy of transfusions of autologous cryopreserved platelets derived from recombinant human thrombopoietin to support chemotherapy-associated severe thrombocytopenia: a randomised cross-over study.
    Vadhan-Raj S; Kavanagh JJ; Freedman RS; Folloder J; Currie LM; Bueso-Ramos C; Verschraegen CF; Narvios AB; Connor J; Hoots WK; Broemeling LD; Lichtiger B
    Lancet; 2002 Jun; 359(9324):2145-52. PubMed ID: 12090979
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of recombinant human thrombopoietin on IL-2, IL-4 and platelet parameters in thrombocytopenic purpura.
    Zhao M; Liang X; Chen C; Du X; Dang X
    Cell Mol Biol (Noisy-le-grand); 2023 May; 69(5):119-125. PubMed ID: 37571891
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhanced retention of in vitro functional activity of platelets from recombinant human thrombopoietin-treated patients following long-term cryopreservation with a platelet-preserving solution (ThromboSol) and 2% DMSO.
    Vadhan-Raj S; Currie LM; Bueso-Ramos C; Livesey SA; Connor J
    Br J Haematol; 1999 Feb; 104(2):403-11. PubMed ID: 10050726
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Clinical Efficacy of Double Plasma Molecular Absorption System Combined with Plasma Exchange in the Treatment of Acute-on-Chronic Liver Failure: A Systematic Review and Meta-Analysis.
    Bai W; Yao C; Mao D; Wu J; Wang K; Wei H; Huang Z; Shi Q; Wang N
    J Healthc Eng; 2022; 2022():3139929. PubMed ID: 35368957
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The clinical study of recombinant human thrombopoietin in the treatment of chemotherapy-induced severe thrombocytopenia].
    Bai CM; Zou XY; Zhao YQ; Han SM; Shan YD;
    Zhonghua Yi Xue Za Zhi; 2004 Mar; 84(5):397-400. PubMed ID: 15061993
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of Recombinant Human Thrombopoietin for the Treatment of Secondary Failure of Platelet Recovery After Allogeneic HSCT.
    Cao Y; Wang M; Shen B; Zhao F; Zhang R; Chen X; He Y; Zhai W; Ma Q; Wei J; Huang Y; Yang D; Pang A; Feng S; Jiang E; Han M
    Clin Appl Thromb Hemost; 2022; 28():10760296211068037. PubMed ID: 35019756
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recombinant human thrombopoietin in combination with granulocyte colony-stimulating factor enhances mobilization of peripheral blood progenitor cells, increases peripheral blood platelet concentration, and accelerates hematopoietic recovery following high-dose chemotherapy.
    Somlo G; Sniecinski I; ter Veer A; Longmate J; Knutson G; Vuk-Pavlovic S; Bhatia R; Chow W; Leong L; Morgan R; Margolin K; Raschko J; Shibata S; Tetef M; Yen Y; Forman S; Jones D; Ashby M; Fyfe G; Hellmann S; Doroshow JH
    Blood; 1999 May; 93(9):2798-806. PubMed ID: 10216073
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of recombinant human thrombopoietin (rhTPO) on sepsis patients with acute severe thrombocytopenia: a study protocol for a multicentre randomised controlled trial (RESCUE trial).
    Zhou Z; Feng T; Xie Y; Huang P; Xie H; Tian R; Qian B; Wang R
    BMC Infect Dis; 2019 Sep; 19(1):780. PubMed ID: 31492102
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Evaluation of recombinant human thrombopoietin in the treatment of chemotherapy-induced thrombocytopenia in lung cancer patients].
    Xu YH; Chen ZW; Ye XY; Lu S
    Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):716-9. PubMed ID: 19173920
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recombinant human thrombopoietin attenuates carboplatin-induced severe thrombocytopenia and the need for platelet transfusions in patients with gynecologic cancer.
    Vadhan-Raj S; Verschraegen CF; Bueso-Ramos C; Broxmeyer HE; Kudelkà AP; Freedman RS; Edwards CL; Gershenson D; Jones D; Ashby M; Kavanagh JJ
    Ann Intern Med; 2000 Mar; 132(5):364-8. PubMed ID: 10691586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.